Urinary tract infections (UTI), which are among the most frequent cases of infectious diseases, mainly affect women. The most common treatment approach involves the use of antibiotics, although this solution is not always the most suitable, mainly because of the resistance that bacterial strains develop. Proanthocyanidins are a class of polyphenols, abundantly contained in cranberry extracts, which have shown beneficial effects in the treatment of urinary tract infections, due to their anti-adhesive properties toward bacteria, with respect to the membranes of the cells of the urothelium and intestine, thus reducing their virulence. In this work, we demonstrate via microscopy and scattering measurements how a mixture of cranberry and chondroitin sulfate can form a crosslinked structure with barrier properties. By using a design of experiment (DOE), we optimized the mass ratio to obtain a precipitate between cranberry extract and chondroitin sulfate in the presence of N-acetylcysteine and hyaluronic acid. By using transepithelial electrical resistance (TEER) chambers, we confirmed the barrier properties of the best mixture obtained with the DOE. Lastly, the antibiofilm action was investigated against five strains of Escherichia coli with different antibiotic sensitivity. The precipitate displayed a variable inhibitory effect in biofilm formation with major effects in UTI with an antibiotic resistance profile.

Cranberry/chondroitin sulfate co-precipitate as a new method for controlling urinary tract infections / Caglioti, Concetta; Iannitti, Rossana; Ceccarelli, Giada; Selan, Laura; Artini, Marco; Papa, Rosanna; Malvasi, Antonio; Gentile, MARIA ROSARIA; Del Bianco, Diletta; Apone, Florinda; Angelini, Paola; Palazzetti, Federico; Fioretti, Bernard. - In: ANTIBIOTICS. - ISSN 2079-6382. - 12:6(2023), pp. 1-13. [10.3390/antibiotics12061053]

Cranberry/chondroitin sulfate co-precipitate as a new method for controlling urinary tract infections

Laura Selan;Marco Artini;Rosanna PAPA;Rosaria Gentile;Paola Angelini;
2023

Abstract

Urinary tract infections (UTI), which are among the most frequent cases of infectious diseases, mainly affect women. The most common treatment approach involves the use of antibiotics, although this solution is not always the most suitable, mainly because of the resistance that bacterial strains develop. Proanthocyanidins are a class of polyphenols, abundantly contained in cranberry extracts, which have shown beneficial effects in the treatment of urinary tract infections, due to their anti-adhesive properties toward bacteria, with respect to the membranes of the cells of the urothelium and intestine, thus reducing their virulence. In this work, we demonstrate via microscopy and scattering measurements how a mixture of cranberry and chondroitin sulfate can form a crosslinked structure with barrier properties. By using a design of experiment (DOE), we optimized the mass ratio to obtain a precipitate between cranberry extract and chondroitin sulfate in the presence of N-acetylcysteine and hyaluronic acid. By using transepithelial electrical resistance (TEER) chambers, we confirmed the barrier properties of the best mixture obtained with the DOE. Lastly, the antibiofilm action was investigated against five strains of Escherichia coli with different antibiotic sensitivity. The precipitate displayed a variable inhibitory effect in biofilm formation with major effects in UTI with an antibiotic resistance profile.
2023
n-acetylcysteine; bacterial biofilm; chondroitin sulfate; cranberry; hyaluronic acid; mucosal protector; physical barrier; urinary tract infections
01 Pubblicazione su rivista::01a Articolo in rivista
Cranberry/chondroitin sulfate co-precipitate as a new method for controlling urinary tract infections / Caglioti, Concetta; Iannitti, Rossana; Ceccarelli, Giada; Selan, Laura; Artini, Marco; Papa, Rosanna; Malvasi, Antonio; Gentile, MARIA ROSARIA; Del Bianco, Diletta; Apone, Florinda; Angelini, Paola; Palazzetti, Federico; Fioretti, Bernard. - In: ANTIBIOTICS. - ISSN 2079-6382. - 12:6(2023), pp. 1-13. [10.3390/antibiotics12061053]
File allegati a questo prodotto
File Dimensione Formato  
Caglioti_Cranberry/Chondroitin_2023.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 3.04 MB
Formato Adobe PDF
3.04 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1684866
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 2
social impact